COVID-19: a Catalyst for Change for UK Clinical Oncology

C E Coles, Ananya Choudhury, Peter Hoskin, C M Jones, B O'Leary, T W Roques, H Tharmalingam, F A P Yuille

Research output: Contribution to journalArticlepeer-review


The United Kingdom (UK) has been severely affected by the Coronavirus Disease 2019 (COVID-19) pandemic. As the National Health Service (NHS) has urgently prioritised management of this outbreak, the UK clinical oncology community has had to adapt rapidly to maintain cancer services and training. These unprecedented times have altered countless aspects of cancer care, education and research, providing a legacy that will extend well beyond the pandemic which catalysed them. This editorial focuses on three key themes which distinguish the UK from many other countries.
Original languageEnglish
JournalInternational Journal of Radiation: Oncology - Biology - Physics
Publication statusAccepted/In press - 21 Jun 2020


Dive into the research topics of 'COVID-19: a Catalyst for Change for UK Clinical Oncology'. Together they form a unique fingerprint.

Cite this